LENZ Therapeutics (LENZ) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.32
-1.05
-0.79
-0.52

Details

Expected EPS
-1.047662
Actual EPS
-1.32
Surprise EPS
-0.27
Surprise Percent
-25.99%

Description

⁨LENZ Therapeutics⁩ (⁦LENZ⁩) has reported earnings of ⁦-1.32⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts